Gallus recommends staying active throughout your programcontinuing to work out helps preserve muscle and reinforces the results youre earning
Dosing Comparison# Retatrutide Dosing# Based on Phase 2 clinical trial protocols (investigational only): Starting dose : 0.5 mg weekly subcutaneous injection Escalation : Gradual increase over 12-24 weeks to target dose (up to 12 mg) Target doses tested : 1, 4, 8, and 12 mg weekly Escalation rationale : Extended 24-week escalation for higher doses reduces GI side effects compared to faster 12-week escalation No commercial formulation exists
Tomato: High in lycopene and other antioxidants, tomatoes contribute indirectly to glutathione levels
Tia Tackles Wegovy for women: How it works, why results differ, and what women need to know Published: June 11, 2026 Updated: June 11, 2026 GLP-1 medications are reshaping how the medical community thinks about weight, metabolism, and chronic disease
and 44% randomized to EGRIFTA and 40% randomized to placebo had impaired glucose tolerance, while 9% randomized to EGRIFTA and 10% randomized to placebo had diet-controlled type 2 diabetes mellitus
When GLP-1 medications reduce intrahepatic fat and glycogen by 40 to 50% (as multiple trials have shown), DXA reads that as lean body mass loss
